• Je něco špatně v tomto záznamu ?

Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group

M. Stock, J. Gora, A. Perpar, P. Georg, A. Lehde, G. Kragl, E. Hug, V. Vondracek, J. Kubes, Z. Poulova, C. Algranati, M. Cianchetti, M. Schwarz, M. Amichetti, T. Kajdrowicz, R. Kopeć, G. Mierzwińska, P. Olko, K. Skowrońska, U. Sowa, E. Góra, K....

. 2019 ; 58 (12) : 1720-1730. [pub] 20190808

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006061

Background and purpose: A collaborative network between proton therapy (PT) centres in Trento in Italy, Poland, Austria, Czech Republic and Sweden (IPACS) was founded to implement trials and harmonize PT. This is the first report of IPACS with the aim to show the level of harmonization that can be achieved for proton therapy planning of head and neck (sino-nasal) cancer.Methods: CT-data sets of five patients were included. During several face-to-face and online meetings, a common treatment planning protocol was developed. Each centre used its own treatment planning system (TPS) and planning approach with some restrictions specified in the treatment planning protocol. In addition, volumetric modulated arc therapy (VMAT) photon plans were created.Results: For CTV1, the average Dmedian was 59.3 ± 2.4 Gy(RBE) for protons and 58.8 ± 2.0 Gy(RBE) for VMAT (aim was 56 Gy(RBE)). For CTV2, the average Dmedian was 71.2 ± 1.0 Gy(RBE) for protons and 70.6 ± 0.4 Gy(RBE) for VMAT (aim was 70 Gy(RBE)). The average D2% for the spinal cord was 25.1 ± 8.5 Gy(RBE) for protons and 47.6 ± 1.4 Gy(RBE) for VMAT. The average D2% for chiasm was 46.5 ± 4.4 Gy(RBE) for protons and 50.8 ± 1.4 Gy(RBE) for VMAT, respectively. Robust evaluation was performed and showed the least robust plans for plans with a low number of beams.Discussion: In conclusion, several influences on harmonization were identified: adherence/interpretation to/of the protocol, available technology, experience in treatment planning and use of different beam arrangements. In future, all OARs that should be included in the optimization need to be specified in order to further harmonize treatment planning.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006061
003      
CZ-PrNML
005      
20200526095547.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/0284186X.2019.1648858 $2 doi
035    __
$a (PubMed)31393203
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Stock, Markus $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
245    10
$a Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group / $c M. Stock, J. Gora, A. Perpar, P. Georg, A. Lehde, G. Kragl, E. Hug, V. Vondracek, J. Kubes, Z. Poulova, C. Algranati, M. Cianchetti, M. Schwarz, M. Amichetti, T. Kajdrowicz, R. Kopeć, G. Mierzwińska, P. Olko, K. Skowrońska, U. Sowa, E. Góra, K. Kisielewicz, B. Sas-Korczyńska, T. Skóra, A. Bäck, M. Gustafsson, M. Sooaru, P. Witt Nyström, J. Nyman, T. Björk Eriksson,
520    9_
$a Background and purpose: A collaborative network between proton therapy (PT) centres in Trento in Italy, Poland, Austria, Czech Republic and Sweden (IPACS) was founded to implement trials and harmonize PT. This is the first report of IPACS with the aim to show the level of harmonization that can be achieved for proton therapy planning of head and neck (sino-nasal) cancer.Methods: CT-data sets of five patients were included. During several face-to-face and online meetings, a common treatment planning protocol was developed. Each centre used its own treatment planning system (TPS) and planning approach with some restrictions specified in the treatment planning protocol. In addition, volumetric modulated arc therapy (VMAT) photon plans were created.Results: For CTV1, the average Dmedian was 59.3 ± 2.4 Gy(RBE) for protons and 58.8 ± 2.0 Gy(RBE) for VMAT (aim was 56 Gy(RBE)). For CTV2, the average Dmedian was 71.2 ± 1.0 Gy(RBE) for protons and 70.6 ± 0.4 Gy(RBE) for VMAT (aim was 70 Gy(RBE)). The average D2% for the spinal cord was 25.1 ± 8.5 Gy(RBE) for protons and 47.6 ± 1.4 Gy(RBE) for VMAT. The average D2% for chiasm was 46.5 ± 4.4 Gy(RBE) for protons and 50.8 ± 1.4 Gy(RBE) for VMAT, respectively. Robust evaluation was performed and showed the least robust plans for plans with a low number of beams.Discussion: In conclusion, several influences on harmonization were identified: adherence/interpretation to/of the protocol, available technology, experience in treatment planning and use of different beam arrangements. In future, all OARs that should be included in the optimization need to be specified in order to further harmonize treatment planning.
650    _2
$a mozkový kmen $x účinky záření $7 D001933
650    _2
$a kochlea $x účinky záření $7 D003051
650    _2
$a nádory hlavy a krku $x diagnostické zobrazování $x radioterapie $7 D006258
650    _2
$a lidé $7 D006801
650    12
$a mezinárodní spolupráce $7 D007391
650    _2
$a larynx $x účinky záření $7 D007830
650    _2
$a nádory nosu $x diagnostické zobrazování $x radioterapie $7 D009669
650    _2
$a nervus opticus $x účinky záření $7 D009900
650    12
$a kritické orgány $x účinky záření $7 D058958
650    _2
$a nádory vedlejších dutin nosních $x diagnostické zobrazování $x radioterapie $7 D010255
650    _2
$a parotis $x účinky záření $7 D010306
650    _2
$a fotony $x terapeutické užití $7 D017785
650    _2
$a protonová terapie $x metody $7 D061766
650    _2
$a plánování radioterapie pomocí počítače $x metody $7 D011880
650    _2
$a radioterapie s modulovanou intenzitou $x metody $7 D050397
650    _2
$a počítačová rentgenová tomografie $7 D014057
650    _2
$a tumor burden $7 D047368
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Gora, Joanna $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Perpar, Ana $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Georg, Petra $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Lehde, Alexander $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Kragl, Gabriele $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Hug, Eugen $u MedAustron Ion Therapy Centre, Wiener Neustadt, Austria.
700    1_
$a Vondracek, Vladimir $u Proton Therapy Centre Czech, Medical Physics, Prague, Czechia.
700    1_
$a Kubes, Jiri $u Proton Therapy Centre Czech, Radiation Oncology, Prague, Czechia.
700    1_
$a Poulova, Zuzana $u Proton Therapy Centre Czech, Medical Physics, Prague, Czechia.
700    1_
$a Algranati, Carlo $u U.O. di Protonterapia- Azienda Provinciale per I Servizi Sanitari Trento, Trento, Italy.
700    1_
$a Cianchetti, Marco $u U.O. di Protonterapia- Azienda Provinciale per I Servizi Sanitari Trento, Trento, Italy.
700    1_
$a Schwarz, Marco $u U.O. di Protonterapia- Azienda Provinciale per I Servizi Sanitari Trento, Trento, Italy.
700    1_
$a Amichetti, Maurizio $u U.O. di Protonterapia- Azienda Provinciale per I Servizi Sanitari Trento, Trento, Italy.
700    1_
$a Kajdrowicz, Tomasz $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Kopeć, Renata $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Mierzwińska, Gabriela $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Olko, Paweł $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Skowrońska, Katarzyna $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Sowa, Urszula $u Institute of Nuclear Physics Polish Academy of Sciences, Cyclotron Centre Bronowice, Kraków, Poland.
700    1_
$a Góra, Eleonora $u Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Radiation Oncology, Kraków, Poland.
700    1_
$a Kisielewicz, Kamil $u Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Radiation Oncology, Kraków, Poland.
700    1_
$a Sas-Korczyńska, Beata $u Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Radiation Oncology, Kraków, Poland.
700    1_
$a Skóra, Tomasz $u Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Radiation Oncology, Kraków, Poland.
700    1_
$a Bäck, Anna $u The Skandion Clinic, Uppsala, Sweden. Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Göteborg, Sweden. Department of Radiation Physics, University of Gothenburg, Göteborg, Sweden.
700    1_
$a Gustafsson, Magnus $u The Skandion Clinic, Uppsala, Sweden. Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Göteborg, Sweden.
700    1_
$a Sooaru, Maret $u The Skandion Clinic, Uppsala, Sweden. Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Göteborg, Sweden.
700    1_
$a Witt Nyström, Petra $u The Skandion Clinic, Uppsala, Sweden. Danish Centre for Particle Therapy, Aarhus, Denmark.
700    1_
$a Nyman, Jan $u Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Björk Eriksson, Thomas $u The Skandion Clinic, Uppsala, Sweden. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Regional Cancer Center West, Göteborg, Sweden.
773    0_
$w MED00009028 $t Acta oncologica (Stockholm, Sweden) $x 1651-226X $g Roč. 58, č. 12 (2019), s. 1720-1730
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31393203 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526095543 $b ABA008
999    __
$a ok $b bmc $g 1524919 $s 1096117
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 58 $c 12 $d 1720-1730 $e 20190808 $i 1651-226X $m Acta oncologica $n Acta Oncol $x MED00009028
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace